NCT01580423View on ClinicalTrials.gov

The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

aprepitant

125 mg capsule

DRUG

placebo

capsule identical to aprepitant

Trial Locations (1)

03756-0001

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT01580423 - The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing | Biotech Hunter | Biotech Hunter